Biopharmaceutical Company
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Re-authorization of the Pandemic and All-Hazards Preparedness Act.  NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical Countermeasures.  H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.  FDA regulatory issues.  Issues related to Priority Review Voucher programs. Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines. FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Re-authorization of the Pandemic and All-Hazards Preparedness Act.  NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical Countermeasures.  H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.  FDA regulatory issues.  Issues related to Priority Review Voucher programs. Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines. FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government.  Re-authorization of the Pandemic and All-Hazards Preparedness Act.  NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical Countermeasures.  H.R. 6378, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.  FDA regulatory issues.  Issues related to Priority Review Voucher programs. Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines.
DIS - Disaster Planning/Emergencies BUD - Budget/Appropriations HOM - Homeland Security
1 - SENATE 1 - SENATE 1 - SENATE
DAVIS & HARMAN LLP
1455 Pennsylvania Avenue, N. W., Suite 1200, Washington, DC, 20004, US
THOMAS A DAVIS THOMAS A DAVIS THOMAS A DAVIS